In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ledipasvir Drug Master File in Korea (Ledipasvir KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ledipasvir. The MFDS reviews the Ledipasvir KDMF as part of the drug registration process and uses the information provided in the Ledipasvir KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ledipasvir KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ledipasvir API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ledipasvir suppliers with KDMF on PharmaCompass.